Garland J. Scott sold ELVN
October 1, 2026 · Form 4 insider transaction
Garland J. Scott sold 13,000 shares of Enliven Therapeutics, Inc. at $46.67 per share, a transaction worth $606.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
13,000
Price
$46.67
Total value
$606.7K
InsiderGarland J. Scott
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 1, 2026
Filing dateOctober 5, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was executed in multiple trades at prices ranging from $46.62 to $46.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.